Evaluation of Aliskiren Efficacy by Different Methods of Blood Pressure Measurements (REALITY)

This study has been terminated.
(The participants signed an old version of the informed consent.)
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01060865
First received: February 1, 2010
Last updated: January 10, 2017
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)